The start-up Neuralink, owned by the richest man in the world Elon Musk, announced on Thursday that US regulators had given the company permission to test its brain implants on humans. The US Food and Drug Administration's clearance of a first-in-human clinical research, according to Neuralink, is "an important first step" for its technology. The goal of Neuralink is to connect the human brain and computer directly.

Which diseases will be cured with Neuralink's assistance?

Neuralink has made it clear that the clinical trial's recruitment process has not yet started. The main goal of the Neuralink implant is to create direct communication between the human brain and a computer, Elon Musk previously stated during a presentation in December. In essence, the business intends to implant a chip in the brain of a person, which will track brain activity and send the information to a computer. Neuralink thinks its cutting-edge technology has the ability to treat disorders like autism, depression, and several degenerative ones.

Monkey trials have been conducted

Since a few years ago, Neuralink, a business owned by Musk, has been making progress in this area. The business first announced in July 2019 that Neuralink would be able to undertake its first human tests in 2020. It was first implanted in monkeys' skulls. The business demonstrated its Neuralink implant by having several monkeys "play" some simple video games or move a pointer around the screen during the presentation.